1 Day
Source:
The Boston Globe
_1777370220974_847775619.png&w=48&q=75){kind=small}
Lived as an Alzheimer’s patient but was not
The article discusses the importance of accurate diagnosis for Alzheimer’s disease through biomarker testing. It highlights a personal story of a patient initially misdiagnosed with Alzheimer’s who learned the correct diagnosis after additional testing. Experts emphasize that expanding access to FDA-cleared blood biomarker tests, which can identify Alzheimer’s earlier, is crucial, and legislation in Massachusetts aims to ensure insurance coverage for these tests before the legislative session ends.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)